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INTRODUCTION 
 
 
 Hypertension is one of the leading causes of death and disability among 
adults all over the world. It remains the major risk factor for coronary, 
cerebral and peripheral vascular disease. Essential hypertension comprises 
more than 90% of hypertension1. 
 
 Hypertension is an emerging health problem in India. When majority of 
people come to know that they have hypertension they have already advanced 
into a stage with target organ damage – a fatal stroke or myocardial infarction 
or irreversible renal failure. Unfortunately even in developed countries like 
United States, fifty million people are found to have hypertension. Of these, 
70% are aware of their diagnosis, but only 50% are receiving treatment and 
only 25% are under control2. 
 
 In addition to a primary increase in cardiac function propelled by 
overactive sympathetic nervous system, primary retention of salt and water by 
kidney, other factors contributing to hypertension are hereditary predisposition 
and high sodium and low potassium intake and excretion. 
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 In a country like India, people used to have a diet rich in sodium and 
poor in potassium, and calcium. Many studies have shown that a correlation 
exists between serum calcium and blood pressure. They have shown that a 
decreased intake of sodium and increased calcium intake or both together may 
be effective in prevention or even treatment of hypertension. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 3
REVIEW OF LITERATURE 
 
ESSENTIAL HYPERTENSION: 
 An elevated arterial pressure is one of the most important public health 
problems and despite it’s widely recognized high prevalence and associated 
danger, it remains inadequately treated in majority of the patients. It is 
common, readily detectable, and usually easily treatable and if left untreated 
can lead to serious morbidity and mortality from cardiac, cerebrovascular, 
vascular and renal disease. Adequate hypertension control remains elusive 
because of the asymptomatic nature of the disease for the first 15 – 20 years 
even as it progressively damages the cardiovascular system3. Although our 
understanding of the pathophysiology of hypertension has increased in 90% to 
95% of cases, etiology is still mostly unknown4. 
 
Definition and classification: 
 Blood pressure is distributed in a typical bell shaped curve within the 
overall population. As seen in the Multiple Risk Factor Intervention Trial 
(MRFIT), the long term risks for cardiovascular mortality rise progressively 
over the entire range of blood pressure, with no threshold that clearly 
identifies the potential danger. Therefore the definition of hypertension is 
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somewhat arbitrary and usually taken as that level of pressure associated with 
doubling of long term risks. 
 
 According to JNC (Joint National Committee) 7 report, in adults 
aged18 years and above, systolic blood pressure of <120 mm of Hg and 
diastolic blood pressure of <80 mm of Hg is normal. Systolic blood pressure 
of 120 – 139 mm of Hg and diastolic blood pressure of 80 – 89 mm of Hg is 
prehypertension. In stage I hypertension, the systolic blood pressure is 140 – 
159 mm of Hg and diastolic blood pressure is 90 – 99 mm of Hg. In stage II 
hypertension, systolic blood pressure is ≥ 160 mm of Hg and diastolic blood 
pressure is ≥ 100 mm of Hg5. 
Table – I 
JNC 7 Classification of Blood Pressure for Adults ≥ 18 years* 
Sl. No. Category 
Systolic BP 
(mm of Hg) 
 
Diastolic BP 
(mm of Hg) 
1. Normal <120 and <80 
2. Prehypertension 120-139 or 80-89 
Hypertension 
Stage I 
 
140-159 
 
or 
 
90 -99 3. 
Stage II ≥160 or ≥100 
* ( Source, JAMA 2003; 289:2560) 
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Prevalence: 
 Cardiovascular diseases account for a large proportion of all deaths and 
disability worldwide. In 1990 there were 5.2 million deaths from 
cardiovascular diseases in economically developed countries and 9.1 million 
deaths from the same causes in developing countries. In 1990 in India, out of 
9.4 million total deaths, cardiovascular diseases caused 2.3 million deaths 
(25%), 1.2 million deaths were due to coronary heart disease and 0.5 million 
were due to stroke6. It has been predicted that by 2020, there would be a 
11.1% increase in cardiovascular deaths in India. Hypertension is a major 
cardiovascular risk factor and important public health problem in the Indian 
subcontinent and among the South Asians world-wide7, 8. 
 
 Hypertension is directly responsible for 57% of all stroke deaths and 
24% of all coronary heart disease deaths. This fact is important because 
hypertension is a controllable disease and a 2 mm Hg population-wide 
decrease in blood pressure can prevent 1,51,000 stroke and 1,53,000 coronary 
heart disease deaths in India9, 10. 
 
The average BP levels in China were systolic: 118±18 mm Hg and 
diastolic: 76.6±11 mm Hg in a sample of 10,076 urban and rural subjects 35-
54 years of age. In India Gupta et al reported mean systolic BP (men: rural 
127±14, urban 125±17; women: rural 124±13, urban 126±18) and diastolic BP 
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(men: rural 81±8, urban 81±9; women: rural 80±8, urban 81±12) levels in 
western Indian urban and rural subjects aged ≥20 years11. Systolic BP has 
increased in Indian men aged 40-49 years from 123±11 mm Hg in 1959 to 
128.8±17 mm Hg in 199512. 
 
Recent studies among Indians have shown a high prevalence of 
hypertension in both urban and rural areas13,14. The prevalence rate of 
hypertension in India done by various study groups is shown in the Table – II 
given in the next page. 
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Table - II 
Recent Indian Hypertension Prevalence Studies (BP >140/90) # 
 
Sample size 
 
 
Prevalence (%) 
 
First author 
Age 
group 
 
Place 
Men Women Men Women 
Gupta R 
 
1995 
20-75 Jaipur 1415 797 29.5 33.5 
Joseph A 
 
2000 
20-89 Trivandrum 76 130 31 41.2 
Anand MP 
 
2000 
30-60 Mumbai 1521 141 34.1* - 
Mohan V 
2000 
20-70 Chennai 518 657 14* - 
Gupta R 
2002 
20-75 Jaipur 550 573 36.4 37.5 
Gupta PC 
2004 
18-60 Mumbai 40067 59522 43.8 44.5 
* Gender specific data not available 
# (Source, J Human Hypertension 2004; 18: 73-78) 
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Awareness status of hypertension in India is poor. In urban population 
of Mumbai there was a very low awareness of hypertension and only 6.1% 
males and 10.1% females were aware of the hypertension in early 1990`s15. In 
Jaipur also it has been reported that only 11% of male and 16% of female 
hypertensives were aware of their condition16. Higher awareness of 
hypertension has been reported among the more educated populations in 
Kerala and among Parsis in Mumbai17,18. In community dwelling elderly 
individuals in Kerala (n= 357, mean age 70 years) hypertension was present in 
51.8% subjects and 44.9% of these individuals were aware of their 
condition17. Bharucha and Kuruvilla18 reported that 53% of men and 44% of 
women were unaware of their hypertensive status although 905 had their BP 
measurement in their past. This level of awareness is similar to reported from 
many developed countries and shows that within India there is a wide 
variation in hypertension awareness status. 
 
Natural History and Complications: 
The pathological hallmark of untreated hypertension is acceleration of 
atherosclerosis. The higher the BP, the more likely that various cardiovascular 
diseases will develop prematurely. If untreated, 50% of the hypertensive 
patients die of coronary artery disease or congestive cardiac failure, about 
33% of stroke and 10 – 15% of renal failure. A meta-analysis of nine major 
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prospective studies shows a direct continuous and apparently independent 
association of diastolic BP with both coronary artery disease and stroke19.  
 
In general the vascular complications of hypertension can be 
considered as either hypertensive or atherosclerotic. 
 
I. Hypertensive Complications: 
1. Accelerated malignant phase 
2. Hemorrhagic stroke 
3. Congestive heart failure 
4. Nephrosclerosis 
5. Aortic dissection 
 
II. Atherosclerotic Complications: 
1. Coronary artery disease 
2. Sudden death 
3. Arrhythmias 
4. Atherothrombotic Stroke 
5. Peripheral vascular stroke 
 
Overall Cardiovascular Risk: 
 The degree of risk from hypertension can be categorized with 
reasonable accuracy by taking into account 
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1. The level of Blood Pressure. 
2. The biological nature of hypertension based on target organ 
damage. 
3. The co-existence of other cardiovascular risk factors (20). 
 The goal of anti-hypertensive therapy should not only be the reduction 
of blood pressure but also treating other risk factors. The major cardiovascular 
risk factors indicated in JNC-7 report are 
 
1. Hypertension 
2. Cigarette smoking 
3. Obesity  
4. Physical inactivity 
5. Dyslipidemia 
6. Diabetes mellitus 
7. Microalbuminuria or estimated GFR <60 ml/min 
8. Age (>55 for men, >65 for women). 
9. Family history of premature cardiovascular disease (<55 for 
men, <65 for women) 
 
Systolic Hypertension and Pulse Pressure: 
 Systolic blood pressure rises in a linear fashion with age, where as 
diastolic blood pressure increases until the age of fifty then levels off and even 
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begins to fall. Isolated diastolic hypertension is more common in younger 
subjects, while isolated systolic hypertension emerges as the most common 
form of hypertension in the elderly. The underlying pathological process is 
loss of arterial elastic tissue, which means that the pressure was created by left 
ventricular contraction, can no longer be damped by the aorta and major 
vessels. Systolic blood pressure is a better predictor of cardiovascular risk and 
isolated systolic hypertension is now recognized to be an independent risk 
factor of cardiovascular disease. A wide pulse pressure has a similar influence 
on    prognosis21. 
 
Gender Differences: 
 Hypertension is an important risk factor for cardiovascular disease in 
women. Although premenopausal women have lower blood pressure than age 
matched men, the prevalence of hypertension is higher in women than men 
after the age of sixty five. Obesity is significantly more common in middle 
aged and older women and is likely to contribute to cross over in prevalence. 
Oral contraceptive pills increase the risk of hypertension in younger women. 
Hormone replacement therapy does not raise the blood pressure in women 
who are normotensive at the start of treatment. 
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 The ratio of hypertension frequency in women versus men increases 
from 0.6 to 0.7 at age 30 to 1.1 to 1.2 at age 65 years. 
 
Hypertension in black populations: 
 Hypertension is most common in black than in white and more 
common in urban than rural blacks. Black individuals have a higher incidence 
of salt sensitive hypertension than white individuals and retain more sodium 
leading to expanded plasma volumes and lower plasma renin activity. The 
complications of hypertension also tend to be different in blacks with a higher 
incidence of left ventricular hypertrophy, stroke, renal failure and lower risk 
of coronary artery disease. The increased frequency of left ventricular 
hypertrophy and stroke and renal failure is due to severity of hypertension in 
black and lower risk of coronary artery disease than white is due to more 
favourable lipid profiles. 
 
Mechanisms of Primary Hypertension: 
 No single or specific cause is known for most cases of hypertension, 
and the condition is referred to as primary in preference to essential. Blood 
pressure is the product of cardiac output and peripheral vascular resistance 
(BP = CO X PVR). Since persistent hypertension can develop only in 
response to an increase in cardiac output or a rise in peripheral resistance, 
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defects may be present in one or more of the multiple factors that affect these 
two forces. This can be described under the following headings. 
 
1. Non renal factors 
2. Renal factors 
 
I. Non renal factors: 
 Primary hypertension is a complex multifactorial and polygenic 
disorder that results from an interaction between an individual’s genetic 
background and various environmental factors. 
1. Genetic Predisposition: 
In studies of twins and family members in which the degree of familial 
aggregation of blood pressure level is compared with the closeness of genetic 
sharing, the genetic contributions have been estimated to range from 30% to 
60%22. Harrap suggested that “the average population blood pressure is 
determined by the environment but the blood pressure rank within the 
distribution is decided largely by genes23. 
 
Epidemiological data suggest that for population variability in blood 
pressure genetic factors contribute 30 – 35%, common household environment 
about 10 – 15% and non familial factors for the remaining 50 – 55%24. 
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If genetic markers of a predisposition for the development of 
hypertension are found, then specific environmental manipulations could then 
be directed toward the susceptible subjects25. Pratt, from his observation of 
bimodal distribution of blood pressure in some families with hypertensive 
subjects, proposed autosomal dominant mode of inheritance. Pickering 
proposed that blood pressure is a quantitative trait with genetic contribution 
which is polygenic. 
 
Genome wide scanning strategy in sib-pairs has identified 
chromosomal regions on chromosomes 6, 5, 12 and 15 which showed 
significant linkage to genes that influences inter individual blood pressure 
variation. There are several candidate genes within the identified group26. 
 
Polymorphism of genes involving the RAS system, aldosterone 
synthesis and adrenergic receptors has been noted to be more common in the 
hypertensive than normotensive patients27. Genetic abnormalities may be 
monogenic in some rare forms of hypertension like glucocorticoid remediable 
aldosteronism, Liddle syndrome, and apparent mineralocoricoid excess28. 
 
2. Fetal environment: 
Low birth weight as a consequence of fetal under nutrition is followed 
by an increased incidence of high blood pressure later in life with an overall 
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estimate that a 1 kg lower birth weight is associated with a 2 to 4 mm Hg 
higher systolic blood pressure in adulthood29. Brenner and Chertow 
hypothesized that a decreased number of nephrons from the intrauterine 
growth retardation could very well serve as a permanent irreparable defect that 
eventuates in hypertension30. 
 
3. Vascular Remodeling: 
A number of factors increase peripheral resistance by both functional 
contraction and vascular remodeling and hypertrophy. Multiple vasoactive 
substances act as pressure-growth promoters resulting in both vascular 
contraction and hypertrophy simultaneously, but perpetuation of hypertension 
involves hypertrophy. Lever and Harrap31 postulated that primary 
hypertension has two mechanisms similar to secondary hypertension (a) a 
growth promoting process in children, and (b) a self-perpetuating mechanism 
in adults. 
 
4. Neurohumoral causes of primary hypertension: 
A large number of circulatory hormones and locally acting substances 
may be involved in the development of hypertension which causes 
hypertension by vascular hypertrophy, capillary rarefaction and impaired 
microvascular dilation32. 
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A. Sympathetic Nervous Hyperactivity: 
Young hypertensives tend to have increased levels of circulating 
catecholamines, augmented sympathetic nerve traffic in muscles, faster heart 
rate and heightened vascular reactivity to α adrenergic agonists33. 
 
These changes could raise blood pressure in a number of ways – either 
alone or in concert with stimulation of renin release by catecholamines or by 
causing arteriolar and venous constriction or by increasing cardiac output or 
by altering the normal renal pressure – volume relationship. 
 
B. Renin – Angiotensin System: 
Both as a direct pressor and as a growth promoter, the renin – 
angiotensin mechanism may be also involved in the pathogenesis of 
hypertension. All functions of renin are mediated through the synthesis of 
angiotensin II. This system is the primary stimulus for the secretion of 
aldosterone and hence mediates minerlocorticoid responses to varying sodium 
intake and volume overload. When sodium intake is reduced or effective 
plasma volume shrinks the increase in renin – angiotensin II stimulates 
aldosterone secretion, which in turn is responsible for a portion of the 
enhanced renal retention of sodium and water. 
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When large populations of hypertensives are surveyed, only about 30 
percent have low plasma renin activity levels, where as 50 percent have 
normal levels and the remaining 20 percent have high levels34. 
 
Normal and high renin hypertension: 
Some persons with primary hypertension have normal or high renin 
levels. The concept of “nephron heterogeneity”35 descried by Sealy and 
colleagues, assumes a mixture of normal and ischemic nephrons caused by 
afferent arteriolar narrowing. Excess renin from the ischemic nephrons could 
raise the total blood renin level to varying degrees and cause high renin levels 
in patients with primary hypertension. 
 
C. Hyper insulinemia / Insulin resistance: 
 An association between hypertension and hyperinsulinemia has been 
recognized for many years, particularly with accompanying obesity but also in 
about 20 percent of non obese hypertensive patients36. The hyperinsulinemia 
of hypertension arises as a consequence of resistance to the effects of insulin 
on peripheral glucose utilization. This association does not apply to pima 
Indians but it has been found in blacks, Asians and as well as whites.  The 
impairment of the peripheral actions of the insulin result from a defect in the 
usual vasodilatory effect of insulin mediated through increased synthesis of 
nitric oxide, which normally counters the multiple pressor effects of insulin37. 
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These pressor effects include activation of sympathetic activity, a trophic 
action on vascular hypertrophy, and increased renal sodium reabsorption. 
 
 The failure of vasodilation to antagonize the multiple pressor effects of 
insulin presumably eventuates in a rise in blood pressure that may be either a 
primary cause of hypertension or, at least, a secondary potentiator. 
 
D. Endothelial Cell dysfunction: 
 The endothelium is now known to be the source of multiple relaxing 
and contracting substances, of which nitric oxide is an important vasodilator38. 
The impairment of normal vasodilation in the insulin resistance syndrome has 
been shown to involve failure to synthesize the normal endothelium derived 
relaxing factor (NO). 
 
Nitric Oxide: 
 Hypertensive patients have been shown to have a reduced vasodilatory 
response to various stimuli of nitric oxide release that appears to be 
independent of the etiology of the hypertension and the degree of the gross 
vascular structural alteration. Impaired nitric oxide mediated vasodilation may 
promote abnormal vascular remodeling and may be involved in the greater 
propensity for vascular damage in blacks than in whites. Nitric oxide – 
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mediated forearm responsiveness has been restored by normalization of blood 
pressure by anti hypertensive drugs with different modes of action. 
 
Endothelin: 
 Endothelin – 1 causes pronounced and prolonged vasoconstriction and 
because blockade of its receptors improves endothelium – dependent 
vasodilation in hypertensive patients39. 
 
E. Minerals: 
 Excess of lead and changing ratios among dietary sodium, potassium, 
calcium and magnesium have also been postulated in the pathogenesis of 
primary hypertension40. 
 
II. Renal retention of excess dietary sodium: 
 A considerable amount of circumstantial evidence supports a role for 
sodium in the genesis of hypertension. To induce hypertension, some of the 
excess sodium must be retained by the kidneys. Such retention could arise in a 
number of ways. 
 
1. Nephron heterogeneity, described as the presence of a sub population 
of nephrons that is ischemic either from afferent arteriolar 
vasoconstriction or from an intrinsic narrowing of the lumen. Renin 
secretion from this sub group of nephrons is tonically elevated. This 
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increased renin secretion then interferes with the compensatory 
capacity of intermingled normal nephrons to adaptively excrete sodium 
and consequently, over all blood pressure homeostasis35.  
2. A decrease in the filtration surface by a congenital or acquired 
deficiency in nephron number or function.  
3. A resetting of the normal pressure – natriuresis relationship – the 
Guyton hypothesis41. 
4. An acquired inhibitor of the sodium pump or other abnormalities in 
sodium transport42. 
5. Defensive responsiveness to atrial natriuretic hormones43. 
 
Association of hypertension with other conditions: 
1. Physical inactivity: 
 Physical fitness may help prevent hypertension and persons who are 
already hypertensive may lower their blood pressure by means of regular 
isotonic exercise. The relation ship may involve insulin resistance because an 
increased resistance was coupled with low physical fitness in normotensive 
men with a family history of hypertension. 
2. Alcohol: 
 Alcohol in larger amounts (more than two portions a day and more so 
when drunk in binges) increases blood pressure and arterial stiffness. The 
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pressure effect of larger amount of alcohol reflects an increase in cardiac 
output and heart rate, possibly a consequence of increased sympathetic nerve 
activity. Alcohol also alters cell membranes and allows more calcium to enter, 
perhaps by inhibition of sodium transport. 
 
 Alcohol in small amounts (less than one or two usual portions a day) 
provides protection from coronary disease, congestive heart failure, stroke, 
and dementia44. And at least in women, reduces the incidence of 
hypertension45. The reduction in coronary disease in persons who ingest small 
amounts of alcohol may reflect an improvement in lipid profile, a reduction in 
factors that encourage thrombosis, and an improvement in insulin sensitivity. 
 
 Framingham study showed small overall correlation between alcohol 
intake and blood pressure, but prevalence of hypertension was about two times 
higher among persons drinking sixty ounce or more of ethyl alcohol per month 
than among those drinking less than thirty ounce per month46. 
3. Smoking: 
Cigarette smoking raises blood pressure, probably through the nicotine 
induced release of norepinephrine from adrenergic nerve endings. In addition, 
smoking causes an acute and marked reduction in radial artery compliance 
independent of the increase in blood pressure. When smokers quit, a rise in the 
blood pressure may occur, probably reflecting a gain in weight. Numerous 
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studies have shown that smokers are thinner than non smokers and that 
smoking reduces weight. However they will have larger waist hip ratio than 
non smokers47. 
 
4. Hematological Findings: 
Higher hematocrits are found in hypertensive persons and are 
associated with abnormal left ventricular filling on echocardiography48. Whole 
blood viscosity in increased by about 10 percent in persons with untreated 
mild hypertension, comparable to the increase in their peripheral resistance49. 
Pseudo or stress polycythemia with high hematocrit and increased blood 
viscosity but contracted plasma volume, as well as normal red cell mass and 
serum erythropoietin levels are found in hypertension. High WBC count is 
predictive of the hypertension50. 
5. Hyperuricemia: 
Hyperuricemia is present in 25 percent of individuals with untreated 
hypertension, more than 75% of patients with malignant hypertension which 
are about five times the frequency found in normotensive persons51. 
Hyperuricemia probably reflects decreased renal blood flow, presumably a 
reflection of nephrosclerosis. 
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6. Sleep Apnea: 
Snoring and sleep apnea are often associated with hypertension, which 
may in turn be induced by the increased sympathetic activity and endothelin 
release in response to hypoxemia during apnea52. 
 
7. Hypercholesterolemia: 
Hypercholesterolemia frequently coexists with hypertension, at least in 
part because it impairs endothelium – dependent vasodialtion. Lipid lowering 
therapy restores the bioavailability of nitric oxide, reduces arterial stiffness, 
and lowers blood pressure53. 
 
8. Obesity: 
The majority of patients with high blood pressure are overweight and 
hypertension is about six times more common than it is in lean subjects54.  
 
A 10 kg higher body weight is associated with a 3 mm Hg higher 
systolic and 2.3 mm Hg higher diastolic blood pressure. These increases 
translate into an estimated 12% increase in the risk of coronary artery disease 
and 2.24% increase in the risk of stroke. 
 
Body mass index in widely used as a correlation with excess body fat 
or adiposity but it does not convey information on required fat distribution. 
Body fat distribution plays a role as a risk factor for hypertension. An increase 
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in waist hip ratio (WHR) > 0.95 in male and 0.8 in female is an independent 
risk factor for the development of hypertension and is independently 
associated with hypertriglyceride and increased apoprotein – B. The waist 
circumference may be the better indicator of visceral fat than waist hip ratio. 
 
Hip circumference – It is measured at the point of one third of the 
distance between the anterior superior iliac spine and the patella. 
 
Waist Circumference – It is measured half way between superior iliac 
crest and rib cage in mid axillary line. It correlates well with the systolic blood 
pressure and diabetes mellitus. 
 
Body mass index   =    weight in kg   /   height in m². 
 
Table - III 
Proposed classification of weight by BMI in adult Asians (55) * 
Classification BMI  (kg / m²) 
Underweight <18.5 
Normal range 18.5 – 22.9 
Over weight 23 
At risk 23 – 24.9 
Obese I 25 – 29 
Obese II >30 
  * (Source, Am J Clin Nutr. 2000; 72: 1067-1068) 
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Metabolic syndrome: 
 According to ATP III, metabolic syndrome is defined as a cluster of 
cardiovascular risks in a silver individual – normally hypertension, diabetes 
mellitus, abdominal obesity, low HDL, increased TGL, procoagulant tendency 
and increased small LDL. 
 Obese individuals with high waist hip ratio have high incidence of 
hypertension than do with low waist hip ratio56. Visceral obesity is a strong 
risk factor for hypertension. Although body mass index is a very strong 
determinant of blood pressure, a visceral distribution of fat has an even greater 
relationship with the development of hypertension57. 
 
CALCIUM 
 Calcium is an important mineral mainly found in bone and teeth.  
Dietary sources  
 It is widely distributed in food sub such as milk, cheese, egg-yolk, 
beans, lentils, nuts, figs, cabbage.  
Body distribution  
 The total calcium of the body is 25-35 males (100g-170g) about 99% 
and it is found in bones. It exists as carbonate on phosphate and calcium. 
About 0.5% in soft tissue and 0.1% in ECF. The normal level and plasma 
calcium is 9-11mg/dl. The calcium in plasma in and 3 types, namely,  
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• Ionized calcium (diffusible)  
• Protein bound ca++ 
• Complex ca++ 
 About 40% and total calcium is in ionized form albumin is the major 
protein with which calcium is bound. All the three forms and cal+ in plasma 
remain in equilibrium with each other. Ionized calcium in physiologically 
admit form and calcium58.  
 
CALCIUM IN THE PATHOGENESIS OF ESSENTIAL 
HYPERTENSION: 
 Essential hypertension is accompanied by abnormalities of calcium 
homeostasis, including hyperparathyroidism with reduced target organ 
responses to parathyroid harmone in kidney and bone. Hyperparathyroidism is 
also due to an intrinsic defect in renal calcium handling. In subject with a 
genetically determined predisposition to the development of hypertension, a 
high sodium consumption leads to volume overload, which results in the 
appearance of a natriuretic hormone in the circulation87. It has been suggested 
that the excessive excretion of calcium and phosphorous associated with 
exaggerated natriuresis may participate in aberration of calcium metabolism in 
low rennin hypertensive seniles. 
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 By definition, natriuretic hormone causes natriuresis by blocking 
sodium reabsoption in the renal tubles and this blockade appears to involve 
inhibition of the ouabain sensitive Na-K pump that activity extrudes sodium 
into the extracellular fluid. 
 This natriuretic hormone influences membrane permeability which 
leads to an increase in intracellular sodium and by inhibiting sodium calcium 
exchange, causes an accumulation of calcium in vascular smooth muscle cells. 
The increase in intracellular calcium then leads to an increased contractility 
and vascular tone resulting in an augmented peripheral vascular tone resulting 
in an augmented peripheral vascular resistance and consequently in raised 
blood pressure87.  
 Increased intracellular sodium will raise the concentration of free 
calcium within the vascular smooth muscle cells. A number of relations exists 
between sodium and calcium that would explain how this happens. 
Blaustein portrays some of these59:  
1. An inhibition of sodium potassium exchange pumps would depolarize 
the muscle fibre and thereby increase calcium entry through voltage – 
sensitive calcium channels. 
2. An increase in intracellular sodium will result in a smaller sodium (Na) 
electrochemical gradient between the sarcoplasm and external medium, 
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thereby decreasing the extrusion of calcium from the cell via the Na-Ca 
exchange which derives its energy from this gradient. 
3. An increase in intracellular sodium in the presynaptic terminals of 
sympathetic neurons promotes calcium dependent norepinephrine 
release. The norepinephrine releases calcium from intracellular stores. 
However, the higher intracellular sodium acts to increase the 
concentration of intracellular calcium, a very small rise in intracellular 
sodium, can by theoretical calculations, be shown to cause enough of a rise in 
intracellular calcium to increase the resting tone of vascular smooth muscle by 
about 50%. 
Other mechanisms may be responsible for higher intracellular calcium 
in hypertension: 
1. The inner side of RBC members from hypertensive patients. 
2. Passive calcium influx was increased, 
3. ATP-dependent calcium extrusion is reduced in red cells from SHR 
rate. 
In summary, vascular smooth muscle intracellular calcium is likely 
elevated in primary hypertension. Since intracellular calcium directly controls 
vascular contraction and relaxation, the connection to hypertension in obvious. 
Increased vascular tone and reactivity are likely responsible for much of the 
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increased total peripheral vascular resistance that is the primary cause of 
sustained hypertension. 
 The significance of the reduced binding of calcium to the inner aspect 
of the plasma membrane is not clear. Calcium exerts an important regulatory 
effect on various aspects of membrane function and it is possible that the 
reduction in binding is a cause of some of the abnormalities of ion transport. It 
may be, however, that the reduction in binding is merely a marker of an 
alteration in membrane composition. Which results in a reduced availability of 
binding sites. 
RELATION BETWEEN WHOLE BODY CALCIUM METABOLISH 
AND EVENTS AT A CELLULAR LEVEL: 
Evidences suggest some mechanism by which the calcium balance of 
the body as a whole can influence events at a cellular level. The link may 
involve change in the plasma ionized calcium concentration or changes in 
calcium regulating substances such as parathyroid hormone or 1-25 dihydroxy 
vitamin D. A rising concentration of calcium in the extracellular fluid has 
been shown to inactivate certain potential operated calcium channels in tenia 
coil and a falling concentration must have contrary effects. It is probable that 
human resistance vessels respond in a similar way, although the manifest 
response to a rise in calcium concentration is contraction. Parathyroid 
hormone probably acts on cell of many types apart from those of renal tubules 
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and bone, and increase in cytosolic calcium. At concentration, greatly in 
excess of those occurring physiologically. Parathyroid hormone dilates 
resistance vessels, but the effect, if any, of the very small increases observed 
in patients with primary hypertension is unknown. It is possible that a 
mechanism exists by which the free calcium in the intake, but it seems likely 
that the disorder of calcium handling at a cellular level predominantly from 
other causes60. 
 Effect of alteration in calcium intake. If a calcium intake that is 
suboptimal relative to need plays any part in the causation of primary 
hypertension, it would be expected that the administration of calcium 
supplements would lower blood pressure, at least in the early stages of the 
hypertensive process. In rats, the administration of large doses of calcium 
supplements ameliorates the hypertensive process and severe calcium 
deprivation aggravates it. In a well designed and well controlled study, the 
effect of 8 weeks of treatment with a calcium supplement (calcium carbonate, 
25 mmol/day) in 32 normal subjects and 48 patients with mild hypertension 
was observed. In the normal subjects there was little effect, with no more than 
a small but statistically significant fall in supine diastolic pressure. In the 
patients treatment with calcium led after 8 weeks to significant fall in supine 
diastolic pressure, in the supine position and both systolic and diastolic 
pressure on standing position. In another limited placebo-controlled and 
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randomized study, 8 subjects with mild to moderate hypertension were given 
20 mmol calcium daily as sandocal for 8 week periods: mean arterial blood 
pressure fell by less than 1mm of Hg despite a significant increase in urinary 
calcium excretion. 
 Altered calcium metabolism plays a more important role in 
hypertension developing during pregnancy. An increase in platelet calcium 
and RBC sodium have been found in these patients and has been given much 
importance in the initiation and maintenance of hypertension and influencing 
peripheral vascular resistance and also various other factors in the serum of 
PIH (pregnancy induced hypertension) women and these may contribute to the 
accumulation of intracellular ionized calcium in patients with pregnancy(25 
and 50mmol/day) there is a significant reduction in diastolic blood pressure 
during the second trimester and with the larger supplement, the normal 
increases in pressure in the third trimester can be prevented 61. 
 It is of interest that Yamakawa et al 62 have shown that disturbed 
intraplatelet and systemic calcium metabolism may be of predictive value in 
the development of hypertension.  
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AIMS AND OBJECTIVES 
 
1. To study the levels of serum calcium in patients with primary 
hypertension. 
 
2. To correlate the serum calcium levels with blood pressure. 
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MATERIALS AND METHODS 
 
Setting   : The work was carried out in the outpatient department and medical  
     wards of Govt. Rajaji Hospital, Madurai. 
Design of the study   : Analytical study 
Period of the Study   :  One year – February 2005 to January 2006 
Sample size   : 100 cases (70 cases and 30 controls) 
Ethical committee approval   : The present project was approved by the 
ethical committee. 
Inclusion criteria: 
1. Patients with primary hypertension. 
2. Patients whose age was above 18 years were included. 
3. Both sexes were included. 
Exclusion Criteria: 
1. Patients below 18 years. 
2. Patients with renal failure. 
3. Pregnancy. 
4. Patients with secondary hypertension. 
5. Patients on non-steroidal anti-inflammatory agents, antihypertensives, 
diuretics, beta blockers or stimulants. 
6. Patients with malignant hypertension. 
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7. Females on oral contraceptive medication. 
8. Patients with peripheral vascular disease. 
9. Patients with diabetes mellitus. 
10. Patients with acute diarrhoeal diseases. 
 
Consent: 
 The study group thus identified by the above criteria (inclusion and 
exclusion criteria) was first instructed about the nature of the study. Willing 
participants were taken up after getting a written informed consent from them. 
 
Study Subjects and Controls: 
 Seventy newly diagnosed essential hypertensive patients attending the 
medicine OPD or admitted to the medical wards of Govt. Rajaji Hospital for 
the period of one year from February 2005 to January 2006 formed the study 
group. Thirty healthy people were kept as controls. This control group 
comprised of normotensive individuals who were attendants of patients with 
primary hypertension living in the same environment other than their own 
siblings. 
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Details of the Study Subjects: 
 All the patients were subjected to detailed history taking, careful 
physical examination and biochemical analysis to exclude secondary 
hypertension. 
  
 Patient’s height and weight were measured. The body mass index was 
calculated using the formula weight / height ². Patient’s hip and waist 
circumferences were measured. All the peripheral pulses were checked with 
special attention to carotid and the femoral to detect evidence for early 
atherosclerosis. An ocular fundus examination was done to detect 
hypertensive retinopathy. 
 
Patients were informed to refrain from smoking or drinking tea or 
coffee for at least thirty minutes before measuring blood pressure. Then blood 
pressure was measured using the following guidelines. 
 
Guidelines for measuring blood pressure: 
I   CONDITIONS FOR THE PATIENT 
A. Posture: 
1. Sitting postures are usually adequate for routine follow-up. Patient should 
sit quietly with back supported for five minutes and arm supported at the 
level of heart. 
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2. For patients who are over 65, diabetic or receiving anti-hypertensive 
therapy, check for postural changes by taking readings immediately and 2 
minutes after the patient stands. 
 
B. Circumstances: 
1. No caffeine for preceding hour 
2. No smoking for preceding 15 minutes. 
3. No exogenous adrenergic stimulants like phenylephrine in nasal 
decongestants or eye drops for papillary dilation. 
4. A quite, warm setting. 
5. Home readings taken under various circumstances and 24 hour ambulatory 
recordings may be preferable. 
 
II EQUIPMENT: 
A. Cuff Size: 
The bladder should encircle and cover 2/3rds of the arm length. If not, 
place the bladder over the brachial artery; if bladder is small spuriously high 
readings may result. 
 
B. Manometer: 
1. Aneroid gauges should be calibrated every six months against the mercury 
manometer. 
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2. For infants use ultrasound equipment e.g., the Doppler method. 
 
III  TECHNIQUE: 
A. Number of readings: 
1. On each occasion, take at least two readings, separated by as much time as 
practical. If readings vary by more than 5 mm Hg, take additional readings 
until two are close. 
2. For diagnosis, obtain at least three sets of readings a week apart. 
3. Initially, take pressure in both arms, if pressure differs, use arm with 
higher pressure. 
4. If arm pressure is elevated, take pressure in one leg, particularly in patients 
below age 30. 
 
B. Performance: 
1. Inflate the bladder quickly to a pressure 20 mm Hg above the systolic, as 
recognized by the disappearance of the radial pulse. 
2. Deflate the bladder 3 mm Hg every second. 
3. Record the Korotkoff phase V (disappearance) except in children, in whom 
use of phase IV (muffling) is advocated. 
4. If Korotkoff sounds are weak, have the patients raise the arm, open and 
close the hand 5 to 10 times, after which the bladder should be inflated 
quickly. 
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C. Recording: 
Note the pressure, patient position, the arm, cuff size (e.g., 140/90, 
seated, right arm, large adult cuff). 
Urine albumin, sugar, microscopy and pH were done for all the 
subjects. A twelve lead electrocardiogram and chest x ray were also taken.  
Overnight (12 hour) fasting blood sugar and urea was done by using 
Diacetyl monoxime (DAM) technique. Serum creatinine was estimated using 
COBAS auto analyzer. Serum Calcium was estimated using Cresolphthalein 
complexone method, total protein was estimated by biuret method and 
albumin was estimated by BCG method.  
DEFINITIONS USED IN THE PRESENT STUDY: 
Essential Hypertension: 
Hypertension was defined in accordance to the JNC- VII report as 
systolic blood pressure 140 mm of Hg and above and or diastolic blood 
pressure 90 mm of Hg and above. The diagnosis that the hypertension is 
essential and not secondary was made on the overall clinical impression only. 
Laboratory investigations to rule out secondary causes were not done in each 
case. 
Calcium Normal Values: 
The normal range for serum calcium is from 9 to 11 mg/dl. 
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Obesity: 
According to the proposed classification of weight by BMI in adult 
Asians (55), the patients with a BMI <18.5 were classified as underweight, 
1.85 – 22.9 were classified as normal, ≥ 23 were classified as overweight and 
≥ 25 were classified as obese. 
 
Diabetes Mellitus: 
 Patients with fasting plasma glucose ≥ 126 mg / dl or two hour plasma 
glucose ≥ 200 mg / dl or with symptoms of diabetes plus random blood 
glucose ≥ 200 mg / dl were considered to be diabetic. 
Left ventricular hypertrophy: 
Based on the electrocardiographic findings, which satisfy either 
Sokolow-Lyton criteria or Cornell voltage criteria 63,64. 
 
Conflict of interest: 
 There was no conflict of interest. 
Financial Support: 
 Nil. 
Limitations: 
1. Only serum calcium alone done. 
2.  Twenty four hours urinary calcium and arterial blood gas 
analysis were not done due to technical and financial limitations. 
 40
Renal handling of calcium was not attempted as it was beyond 
the scope of the present study. 
3. Hormones related to calcium handling was not estimated. 
4. Serum ionized calcium level was not measured. 
 
Statistical Analysis: 
 The collected data was entered in Microsoft excel spread sheet and 
analysed statistically using epidemiological Information package – 2002 
developed by centers for disease control and prevention, Atlanta in 
collaboration with World Health Organization. Student ‘t’ values were applied 
for significance. Significance was considered if the ‘p’ value was below 0.05. 
 ‘t’ test is used to find out whether or not there exist a mean difference 
between the two groups. If there is then it attempts to see whether or not there 
exist a statistical significant differences between the means of the two groups.  
 
   X1-X2 
  t= --------------------------   with (n1+n2-2) as df  
   SD12 + SD22 
   n1     n2     
 
 X1, X2 = means of two groups  
 SD1, SD2 are standard deviation of two groups  
 n1, n2 are the sample size   
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RESULTS AND OBSERVATIONS 
 
The total number of subjects included in this study was 100. Among 
these 100 subjects, 70 were cases (Hypertensive) and 30 were controls 
(Normotensive). 
 
Analysis of cases and controls with respect to age: 
 The age of the subjects in the study group ranged from forty to sixty 
years. The mean and standard deviation for the age of the cases and controls 
were 53.1 ± 5.37 years and 51.5 ± 5.38 years respectively. The study group 
and the control group did not differ from each other statistically with reference 
to age. 
Majority of the patients in both the study and control group lie between 
41 and 60 years. There was no significant difference in the age composition of 
those with and without hypertension in this study. Almost same age group of 
patients was selected in both groups. 
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 The distribution of the cases and controls in relation to age is provided 
in the Table – IV given below. 
Table – IV 
Distribution of cases and controls in relation to age 
 
Cases Controls 
Age group 
No % No % 
41 – 50 24 34.3 18 60 
51 – 60 46 65.7 12 40 
Total 70 100 30 100 
Mean 53.1 51.5 
S.D 5.37 5.38 
 
The mean age distribution for the males in the case and control groups 
was 52.92 ± 5.52 years and 50.28 ± 5.66 years respectively. The mean age 
distribution for the females in the case and control groups was 53.31 ± 5.27 
years and 51.8 ± 2.17 years respectively. 
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Gender: 
 Among the 70 cases studied, there were 38 males and 32 females. 
Among the 30 controls, there were 20 males and 10 females.  
The details are given in the Table – V provided below. 
 
Table – V 
Distribution of cases and controls in relation to gender 
 
Cases Controls 
Sex 
No % No % 
Male 38 54.3 20 66.7 
Female 32 45.7 10 33.3 
Total 70 100 30 100 
 
 
 
 
 44
Analysis of cases and controls with respect to Body Mass Index (BMI) 
 34.3% of cases were obese while in the control group obesity was 
noticed in 3.3%. The details are shown in the Table – VI given below. 
 
Table – VI 
Distribution of cases and controls with respect to Body Mass Index (BMI) 
 
 
Cases Controls 
BMI 
No % No % 
Underweight <18.5 7 10 3 10 
Normal weight 18.5 – 22.9 24 34.3 20 66.7 
Overweight 23 – 24.9 15 21.4 6 20 
Obese > 25 24 34.3 1 3.3 
Total 70 100 30 100 
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The mean body mass index in the case group is 23.73 ± 3.28 and in the 
control group is 21.36 ± 2.12. The details are given in the Table – VII given 
below. 
 
Table – VII 
BMI among cases and controls 
 
BMI Cases Controls 
Mean 23.78 21.36 
S.D. 3.28 2.12 
‘p’ value = 0.00004 
 
This shows that the difference in Body Mass Index between cases and 
controls was statistically significant. 
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The mean BMI of cases and controls according to gender is given in the        
Table – VIII below. 
 
Table – VIII 
BMI of cases and controls with respect to gender 
 
Male Female 
Group 
Mean S.D. Mean S.D 
Cases 23.78 3.49 23.68 3.07 
Controls 20.9 1.62 23.62 2.21 
 
The mean body mass index in male (case group) is 23.78 and control 
20.9, in female case 23.68 and control 23.62. The details are given in the 
Table VIII. 
 
 
 
 
 47
BMI in relation to the grading of hypertension is furnished in the 
Table– IX given below. 
Table – IX 
BMI with respect to Hypertension 
Grade I Hypertension Grade II Hypertension
BMI 
No. % No. % 
Underweight <18.5 - - 6 8.6 
Normal 18.6 – 22.9 5 7.1 20 28.6 
Overweight 23 – 24.9 4 5.7 11 15.7 
Obese >25 2 2.9 22 31.4 
  
 Body mass index was independent of gender and electrolyte status, but 
it was significantly more in those with grade II hypertension. 
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Analysis of cases with respect to presenting symptoms 
 The most common presenting symptom is giddiness. The other 
symptoms were in the order of headache, chest pain, palpitation and dyspnoea. 
The details of the presenting symptoms are given in the Table – X given 
below. 
Table – X 
Analysis of presenting symptoms 
Male Female 
Symptoms 
No. % No. % 
Nil 1 1.4 1 1.4 
Headache 7 10 1 1.4 
Giddiness 18 25.7 19 27.1 
Chest pain 6 8.6 3 4.3 
Palpitation 4 5.7 8 11.4 
Dyspnoea 2 2.9 - - 
 
 History of headache and chest pain was noticed among men and these 
patients were suffering from very high blood pressure. In contrast history of 
palpitation was elicited more among women. 
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Distribution of cases and controls with respect to cardio vascular risk 
factors 
 Analysis of other risk factors like smoking, alcoholism and family 
history were done among hypertensives. Their details are furnished in the 
Table – XI below. 
Table – XI 
Risk factors among cases and controls 
 
Smoking Alcohol 
Family 
history 
 Yes No Yes No 
Both 
Yes No 
Cases 27 43 10 60 8 10 60 
Control 14 16 6 24 8 - 30 
 
 Since alcoholism and smoking were noticed among men only in this 
part of the country, statistical analysis was not attempted for these risk factors. 
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Blood pressure distribution among cases 
 The details of the blood pressure distribution are given in the Table – 
XII given below. 
Table – XII 
Distribution of systolic and diastolic blood pressure 
Cases Control 
Blood Pressure 
Mean + SD Mean + SD 
Systolic 172.14 ± 15.12 106.53 ± 6.37 
Diastolic 103.29 ± 6.07 71.4 ± 4.24 
 
 The mean systolic blood pressure for the cases was 172.14 ± 15.12 mm 
Hg. Similarly the mean diastolic blood pressure for the cases was 103.29 ± 
6.07 mm Hg. Since the systolic and diastolic blood pressure was elevated in 
cases and it was due to the nature of the disease taken into study, the statistical 
analysis was not done. 
 The mean systolic and diastolic blood pressure distribution for the 
males was 172.63 ± 16.71 mm Hg and 103.42 ± 7.08 mm Hg respectively. 
Similarly for the females the mean systolic and diastolic blood pressure 
distribution was 171.56 ± 13.22 mm Hg and 103.13 ± 4.71 mm Hg 
respectively. There was no statistical significance in the systolic and diastolic 
blood pressure among the cases. 
 51
 The distribution of cases with respect to grading of hypertension is 
given in the Table – XIII given below. 
 
 
Table – XIII 
Distribution of cases with respect to grading of hypertension 
 
 
Grade I Grade II 
Subject 
No % No % 
Cases 11 15.7 59 84.3 
 
 
 From our statistical analysis patients with Grade II hypertension were 
significantly higher than Grade I hypertension.  
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Distribution of cases and controls in relation to serum calcium 
 Serum calcium in the study population varied from 6.9mg/dl to 
10.9mg/dl. The man and standard deviation and serum calcium among cases 
was 8.87±1.07 mg/dl while in control group it was 9.66±0.61mg/dl 
respectively.  
 
 This table clearly shows that the serum calcium level was significantly 
lower among hypertension population studied.  
 
The details are given in Table XIV 
 
Case  Control   
Mean  SD Mean  SD 
t value  ‘p’ value 
Serum 
calcium  
70 
8.87 
1.071 30  
9.66 
0.617 4.62 p<0.05 
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Serum calcium in relation to systolic BP  
 The mean value of serum calcium was 8.90 in Grade I systolic BP and 
8.85 in Grade II systolic BP among cases.  
 
 The mean value of serum calcium was 9.66 among controls. This is 
shown in table XV given below. This table clearly shows that the serum ca++ 
level was significantly lower among Grade II systolic BP cases studied. 
 
The details are given in Table XV 
 
Systolic BP Mean  S.D t value  ‘p’ value 
Grade I 8.90 1.082 
Grade II 8.85 1.076 
0.18 p<0.05 
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Serum calcium in relation to diastolic BP  
 The mean value serum calcium was 9.20 in mg/dl Grade I systolic BP 
of 8.86 in Grade II diastolic BP among cases. The mean value of serum 
calcium was 9.66 among controls. This is shown in Table XVI given below. 
This Table clearly that the serum calcium level was significantly lower among 
Grade II diastolic BP cases studied.  
 
The details are given in Table XVI 
 
Diastolic  BP Mean  S.D t value  ‘p’ value 
Grade I 9.20 0.70 
Grade II 8.86 1.08 
0.65 p<0.05 
 
Serum Calcium in relation to age  
 Serum calcium in the study population varied from 6.9mg/dl to 10.9 
mg/dl. Correlation between age (case and control) and serum calcium is – 
0.1863 i.e., KARL PEARSON’S r = -0.1863. It shows that negative 
correlation between age and serum calcium but non significant. Correlation 
between age in systemic hypertension and serum calcium is -0.1157 i.e., 
higher the age less the serum calcium but this value is not significant. KARL 
PEARSON’S r = -0.1157.    
 
 55
Correlation between sex and serum calcium 
For total population  
The details are given in Table XVII 
Sex N Mean S.D ‘ t ’value ‘P’ value 
Male   60 9.211 1.02 
Female 40 8.955 1.01 
1.24 
 
P> 0.05 
not significant 
       
 
 Sr. calcium in the total population varied from 6.9ms/dl to 10.9ms/dl. 
The mean & S.D of Sr. calcium among male was 9.21 ± 1.02 while in female 
it was 8.95 ± 1.02 while in female it was 8.95 ± 1.01 respectively. 
 
For SHT Patients group  
The details are given in Table XVIII 
Group N Mean S.D ‘t’ Value “p” value 
Male 40 8.99 1.11 
Female 30 8.71 1.01 
1.10 P > 0.05 
(N.S) 
 
 In SHT patients, the mean and SD of serum calcium among male was 
8.99 ms/ dl ± 1.11 in female systemic hypertension patient (40) was 8.71 ± 
1.01   buts ‘p’ value in not significant. 
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For control group: 
The details are given in Table XIX 
 
Group N Mean S.D ‘t’ Value “p” value 
Male 40 9.65 0.631 
Female 10 9.68 0.620 
-0.12 P > 0.05 
(N.S) 
        
 
 The mean and SD of serum calcium among male was 9.65 ± 0.63 and 
in female control serum (10) was 9.68 ± 0.620. This table clearly show that 
serum calcium level in negative correlation but not significant.  
  Correlation = -0.0287 
 
 
Areas for further research 
1. To identify the markers of hypertension prone population. 
 
2. To find out the genes responsible for calcium handling and if required 
to develop a biomolecule to overcome the effects of the mediators of 
which signal / control the calcium at the molecular level. 
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DISCUSSION 
 
 Hypertension is one of the leading causes of death and disability among 
all over the world. Hypertension the most common form and cardiovascular 
disease is present nearly 25% of adults and increases in prevalence with age. It 
remains the major risk factor for coronary, central and peripheral vascular 
disease. Essential hypertension comprises more than 90% of hypertension1.   
 Patients were studied on the basis of clinical parameters and simple 
biochemical investigations serum calcium and albumin was done for all the 
patients.  
 In our study the mean serum calcium was estimated in the control and 
study groups. Results were compared with other studies.  
 Serum calcium was lower in the hypertensive group than the control 
group eventhough both were with in normal range. The mean and standard 
deviation of serum calcium among cases was 8.87±1.07mg/dl while in control 
group if was 9.66±0.61mg/dl respectively.  
 Our study was supported by P.P.Readdy et al (2004), O Stmania 
University, Resumpet, Hyderabad. In his study serum calcium levels were 
measured in 117 subjects with E.T. and 77 first degree relatives. The results 
showed that serum calcium levels the significantly (p<0.01) decreased in both 
males: females with essential hypertension and their first degree relatives 
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when compared with the normotensive controls. This is the first study in 
Indian population63. 
 In Tromso study conducted in northern Norway, U large health surveys 
have been performed the first 1974 of last in 1994-1995. Total serum calcium 
levels were measured in 12865 men and 14293 women between ages and 25 
and 97 years. With the use of sex specific multiple linear regression model 
with age calcium and body mass index cholesterol, HDL, triglycerides, 
systolic and diastolic blood pressure and pulse as possible covariates, serum 
calcium was significantly (p<0.001) and positively association with systolic 
and diastolic blood pressure, serum cholesterol and HDL cholesterol in both 
sexes.    
 In Tillman DM and Semple PF study shows that disturbance of calcium 
metabolism have been described in hypertension, measurement of plasma and 
serum concentration of ionized calcium, total calcium, magnesium and serum 
were made in 38 patients with E.T. and age and sex-matched control subjects. 
Urinary excretion of calcium, magnesium and sodium was also determined. 
The mean serum concentration and ionized calcium was 1.23±0.04 (SD) 
mmol/l in HT group and 1.21±0.03mmol/l in control and results were similar 
after correction for pH. There was a weak positive correlation between serum 
ionized calcium pH 7.4 and systolic pressure (r=0.26, p less than 0.02) but no 
correlation with plasma renin concentration. Although the difference between 
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serum total calcium concentration in the hypertensive (2.29±0.09mmol/l) and 
control (2.26±0.01mmol/l) subject was not significant, there was significant 
correlation between total calcium and systolic pressure (r=0.23, p<0.05) which 
was maintained after correction for other variables64.  
 In Touyz RH et al study conducted in Johannesburg, South Africa, 
states that the heterogeneous status of magnesium and calcium metabolism in 
hypertensive population may be related to the plasma renin activity (PRA). 39 
normotensive (20 black, 19white) and 47 hypertensive (2 black, 22 white) 
subjects were studied. PRA and ionized calcium were significantly lower in 
black hypertensive as compared with the white hypertensive group (1.99±0.3 
vs 5.6±1.02ng) ml/h for RA; 1.28±0.07 vs 1.42±0.01mmol/l for ionized 
calcium : black hypertensives as compared with white hypertensives group 
(p<0.05). Ionized calcium was significantly increased (p<0.05) in white 
hypertensive patient as compared with the normotensive control (1.42±0.01 vs 
1.29±0.04 mmol/l)65.  
 In shone AC study states that serum ionized calcium and pH : effects of 
blood storage, some physiological, influences of a comparison between 
normotensive and hypertension subjects. We proceeded to examine a group of 
age, sex and race matched hypertension and normotensive subjective under 
standardized conditions designed to minimize such technical and 
physiological artifacts. Ionized calcium was not significantly different in the 
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two groups. However, serum pH was significantly elevated in the hypertensive 
group. In the combined group of normotensive and hypertension subjects, 
serum pH was significantly correlated with blood pressure66.  
 In Lind L study states that a pattern of negative calcium balanced with 
lowered levels of serum ionized calcium (ca2+) increased urinary excretion of 
calcium has been reported in hypertensive men. In a present study 10 
untreated hypertensive subjects were salt loaded (20 gram Nacl) for one week 
after a weak on a low salt diet (3g). The change in mean blood pressure at the 
end of the high compared with the low salt diet was called salt sensitivity and 
was related to index of mineral metabolism. It was found that salt sensitivity 
and was related to indexes of mineral metabolism. It was found that salt 
sensitivity was significantly correlated with both plasma ionized ca+ and 
serum calcium concentration both r=0.64, p<0.05 on different diet. Salt 
loading increased the urinary excreation and calcium by 95% and also induced 
reduction in Hb, serum albumin and serum calcium (p<0.0001). In conclusion, 
low levels and plasma ionized calcium and serum calcium where mainly 
support in hypertensive subjects with a low sensitivity to salt. The findings 
support the view that calcium metabolism in related to the regulation of BP67.  
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SUPPLEMENTATION OF CALCIUM OF ITS RESPONSE IN 
VARIOUS STUDIES    
Location & 
population 
Sample size 
age 
Pt conditions & 
study design 
Ca+ dose 
duration 
Results 
Guatemala 
198368 
N=57 
Age 18-35 
S/P 1g/ 22 weeks  ↓ in HT no 
change in 
NTN 
Oregon 
198569  
n=48 HTN  
n=32 (N) 
Age 21-70 
NTN/HTN / 
cross over  
1g/ 8 weeks  ↓ in HT: no 
change in 
NTN 
England 
198670 
n=8 
Age 20-43 
NTN/CR 1.8g/ 
controlled diet 
1 week 
No change  
Netherlands 
198671 
n=90 
Age 16-29 
Double blind  1g/ 12 weeks  ↓ in DBP 
Australia 
198672 
n=47 HTN  
n-48 NTN 
Mean age  
Placebo 60±3 
10mmol 53±5 
20mmol 59±3 
NTN / HTN / 
S/P 
10mmol-
20mmol/2mths  
No change  
Italy 198673 n=18 
Mean age 43±9
Mild HTN S/P 
D-B: CR  
1gm/15 weeks  ↓ in standing 
SBP 
Japan 198674 n=14 
Mean age 71 
(ca2+) 
73 (ca2+d3) 
HTN 2gca2+/ 
2gca2++D3/ 8 
weeks  
↓ sys BP ca2+ 
no change in 
ca2+ D3 
Indiana 
198775 
n=75 men  
Age 19-52 yrs  
NTN  
S/P 
1.5g/ 
12weeks  
↓ SBP 
↓ DBP 
South Dakota 
198776 
n=24 women  
Mean age 
57±9.5 
Mild HT 1g / 12 weeks  ↓ in SBP 
Greece 
198777 
n=18 
Age 25-60 
Mild / mod HT 
S/P: CR 
1gm/ 5 days  ↓ in SBP 
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Location & 
population 
Sample size 
age 
Pt conditions & 
study design 
Ca+ dose 
duration 
Results 
England 
198778 
n=18 
Age 28-65 
Mild /mot 
HT/S/P/CR :  
D-B 
1.6gm/1 month  No change  
Italy 198779 n=8 
Mean age 40±3
Mild HTN S/P: 
D-B:CR 
1gm/ 3weeks  No change  
California 
199180 
n=19 
Age 30-65 
Mild HTN  
D-B:CR 
1.2gm/3mths  No change  
Japan 199181 n=9 
Age 65-86 
HTN CR 1gm/8 weeks  ↓ed in mean 
pressure  
Oregon 
199282 
n=103 
Age 50-80 
HTN  
D-B 
1gm/ 
12/42 weeks  
No mean 
difference @ 
12 weeks  
Indiana  
199283 
n=42 
Mean age: 
placebo  
35.9±15.7 
Rx32.3±10.7 
HTN  
D-B 
1.5gm 8 weeks  ↓ in mean 
pressure  
US 
Multicenter 
1992 
(TOHP)84 
n=237ca2+ 
n=237 placebo 
Age 30-54 
S/P D-B 1/6mths No change  
 
 HTN - Hypertension   NTN  - Normotinsive  
 S/P - Supplement / Placeto  D-B -  Double  blind  
 CR - Cross Over  
   
 With respect to blood pressure, the clinical trial findings when calcium 
intake is increased are conflicting, but there is a trend toward a positive effect 
with calcium supplements of 1.0 to 1.55 per day. The findings have been 
highly variable across studies and within studies but the largest study      
(TOHP) - Trials and Hypertension Prevention Study found no significant 
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blood pressure lowering at 600mg per day.  Investigators have analyzed their 
data retrospectively and found sub group and “calcium responders”. These 
responds had a persistently lower blood pressure. An analysis to salt 
sensitivity has been made, but similar practical problem arises. There is no 
independent and prospective means of identifying those blood pressure will 
respond to calcium, just as there is no means of determining salt sensitivity 
before actually implementing therapy (or) experimental study. Hypertension 
has a complex etiology with multiple factors responsible for its development 
and maintenance. Thus it would be expected that certain subgroups of 
individuals might he responsive to an intervention while other would not. 
However there are practical limitation with respect to research and practice 
related to post hoc designation of responsive individuals. Design of studies of 
efficacy need a means of identifying possible responsiveness before initiates a 
trial of therapy. Similarly if only selected individuals benefit, there should be a 
selection and patient to receive the therapy before initiating treatment unless 
the therapy has seen shown to have important benefit on all potential 
recipients. Diuretics and other pharmacological agents have a generally 
beneficial effect on all treatment candidates.  
  
 Based on the data and experience available, calcium supplementation 
on increased dietary intake of calcium rich foods would be recommended for 
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treatment of hypertension non-specifically for prevention of hypertension. 
Some other studies are not supporting calcium therapy for treatment and 
prevention of hypertension, still calcium can be used because of the other 
benefits like prevention of osteoporosis. Therefore, a recommendation that 
calcium intake be maintained at 1.0 to 1.5gm per day through dietary intake 
on supplements on both can be made for adolescents and adults. This level 
should be sufficient to achieve a blood pressure lowering response in those 
who are responsive.           
 
BMI and Hypertension:  
In our study the mean BMI among the study group was 23.73 ± 3.28 
and among the control group was 21.36 ± 2.12. The ‘p’ value was .00004. 
This shows that overweight and obesity also plays a role in the development 
of essential hypertension. 
  
 This was supported by a study conducted by Stamler54. They showed 
that the hypertension is about six times more common in obese than it is in 
lean subjects. The present study concurs with above observation. However 
body mass index was not related to electrolyte levels. 
 Similarly a study conducted by Huang stated that even a small amount 
of weight gain is associated with a marked increase in the incidence of 
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hypertension85. This study showed a positive correlation between BMI and 
blood pressure which supported our study. 
 In INTERSALT, the relationship between body mass index (kg/m2) 
and blood pressure was studied in 10,079 men and women aged 20-59, 
sampled from 52 centres around the world, based on a standardized protocol 
with central training of observers, a central laboratory and extensive quality 
control. Body mass index-blood pressure relationships were first studied in 
men and women within each centre, and results of these regression analyses 
were then pooled for all 52 centres. With adjustment for age, alcohol intake, 
smoking, and sodium and potassium excretion, body mass index was 
positively associated with systolic blood pressure among men in 51 of 52 
centres and among women in 47, significantly so in 24 and 27, respectively. 
Body mass index was positively associated with diastolic blood pressure in 51 
and 49 centres in men and women, respectively, significantly so in 33 and 31. 
Overall, a 10 kg difference in body weight was associated on average with a 
3.0 mmHg difference in systolic and a 2.2 mmHg difference in diastolic 
pressure. In further analyses across centres, median body mass index was 
related significantly to median systolic blood pressure, median diastolic 
pressure and the prevalence of hypertension in both men and women. Body 
mass index was related to the slopes of systolic and diastolic blood pressure 
with age in women, but not in men86. 
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CONCLUSION  
 
 The following were derived for our study 
 
1. Serum Calcium was significantly less among Hypertension and 
correlated negatively with blood pressure. 
 
2. In view of the significant changes Serum Calcium among Hypertensive 
population, community must be motivated to consume Calcium rich 
diet as a form of primary prevention for essential Hypertension.   
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SUMMARY 
 
 Essential hypertension is a major risk factor for coronary crebral and 
renal vascular disease. Etiology for essential Hypertension is not known many 
theories were postulated. 
  
 The present study attempts to focus the serum calcium level among     
isolated newly diagnosed essential Hypertension who were free from any 
other illness (or) under any medication and to correlate Sr. calcium status with 
the blood pressure Sr. calcium was estimated in seventy hypertensive (M= 38, 
F=32; mean age 53.1±5.37) & thirty health controls (M=20; f=10; mean age 
51.5±5.38). Efforts were also made to final out an also between body mass 
index and waist circumference with systolic & diastolic blood pressure. Blood 
mass index was significantly more in those with stage II hypertension 
however it was independent of gender and Serum Calcium. Mean Serum 
Calcium level was significantly lower among hypertensive when compared to 
healthy controls. The blood pressure also correlated positively with body mass 
index and waist circumference where as negatively correlated with Serum 
Calcium. 
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PROFORMA 
 
Name:    Age:  Sex: M / F Diet: V / NV 
Address:     Occupation: 
 
SYMPTOMS: 
⁯ Headache   ⁯ Oliguria  ⁯ Giddiness 
⁯ Puffiness of face  ⁯ Blurring of vision ⁯ Epistaxis 
⁯ Swelling of legs  ⁯ Anorexia  ⁯ Chest pain 
⁯ Vomiting / Hiccups ⁯ Palpitation  ⁯ Easy fatiguability 
⁯ Dyspnoea   ⁯ Polydipsia  ⁯ Polyuria 
⁯ Bony pain    ⁯ Colicky abd pain   
 
PAST HISTORY 
⁯ DM    ⁯ Angina / MI ⁯ Heart Failure 
⁯ Renal Disorders  ⁯ PVD  ⁯ Stroke 
⁯ Thyroid Surgery / Radiation    ⁯ Bony fracture / abnormality  
 
PERSONAL HISTORY 
⁯ Smoking   ⁯ Alcohol  ⁯ Drug abuse 
⁯ Dietary milk quantity – ML  
 
FAMILY HISTORY 
⁯ Hypertension  ⁯ Diabetes Mellitus 
 
 
 
ANTHRPOMETRY 
Ht cm   Wt kg  BMI 
Hip cm   waist cm  WHR 
 
GENERAL EXAMINATION 
Fundus   Blood pressure 
Pedal edema   Supine   Sitting 
Pulse Rate   Grading of Hypertension 
 
SYSTEMIC EXAMINATION 
CVS     RS 
ABD     CNS 
 
INVESTIGATIONS 
Urine Albumin 
            Sugar 
 Deposits 
Blood Glucose 
 Urea 
Serum Creatinine 
ECG 
CXR PA VIEW 
Serum Calcium  
 Corrected calcium  
 Total protein  
 Albumin  
 Globulin  
MASTER CHART 
 
0 – no symptom 1 – headache  2 – giddiness  3 – chest pain   4 – palpitation   5 – dyspnoea   
M – male F- female;   P/H – past history   1 - No        2 – Yes  
Smoking  1 – Yes  2 – No;  Alcohol    1 – No  2 – Yes   
F/H – family history 1 – No   2 – Yes   
ECG  1 – Normal  2 – LVH      3 – LAHB  
Chest X ray (CXR)  1 – Normal  2 – Cardiomegaly    
Fundus   0 – Normal  1 – grade I ht retinopathy   
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Fig. 1 Prevalence of hypertension in India over the years 1998-2004* 
 
 
* Source: Gupta R: Trends in Hypertension epidemiology in India: J Hum 
Hypertens 2004: 18; 73-78. 
 
 
Chandigarh  Urban 11.59%±1.0 [Chadha SL 1998]  
Rural 3.58%±0.5 [Chadha SL 1998]  
(13.11%±1.0  
(Thakur K 1999)  
Jaipur  
36.4%  Male  
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Fig – 1 
Distribution of cases and controls in relation to age 
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Fig – 2 
Distribution of cases and controls in relation to gender 
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Fig – 3 
Distribution of cases and controls with respect to  
Body Mass Index (BMI) 
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Fig – 4 
BMI among cases and controls 
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Fig – 5 
BMI of cases and controls with respect to gender 
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Fig – 6 
BMI with respect to Hypertension 
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Fig – 7 
Analysis of presenting symptoms 
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Fig – 8 
Distribution of systolic and diastolic blood pressure 
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Fig – 9 
Distribution of cases with respect to grading of hypertension 
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Fig – 12 
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Fig – 11 
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Fig – 10 
 
 
Distribution of cases and controls in relation to 
serum calcium
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